NCT04161768

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Comparative Study of Norfloxacin Versus Norfloxacin With Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Detailed description

Comparative Study of Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Conditions

• Spontaneous Bacterial Peritonitis

Interventions

Type	Name	Description
DRUG	Norfloxacin	Norfloxacin 400 mg daily
DRUG	Itopride	Itopride 50 mg three times daily

Timeline

• Start date: 2018-12-01
• Primary completion: 2028-12-01
• Completion: 2028-12-01
• First posted: 2019-11-13
• Last updated: 2019-11-13

Locations

1 site across 1 country: Egypt